NCT03285178 · Interventional trial
A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
Overall registry status Completed
Phase 2
Conditions Sickle Cell Disease
Delaware Valley sites
- The Clinical Trial Center LLC · Jenkintown, PA · Montgomery County
First posted
Registry updated
Added to the directory